聚光科技(300203.SZ):擬售安譜實驗約25.18%股權 預計增加並表利潤總額3.9億元
格隆匯 11 月 3日丨聚光科技(300203.SZ)公佈,公司於2020年11月3日召開第三屆董事會第十三次會議,審議通過了《關於出售控股子公司部分股權的議案》,擬出售上海安譜實驗科技股份有限公司(“安譜實驗”或“目標公司”)1000萬股(約25.18%)的股權,標的股份的每股轉讓價格為人民幣36元。
此次交易不構成關聯交易,不構成《上市公司重大資產重組管理辦法》規定的重大資產重組,該事項尚需提交股東大會審議。
此次交易若順利實施,將增加公司的營運資金,有利於優化公司資產結構,預計此次交易將增加2020年度合併報表利潤總額約3.9億元人民幣。對公司財務數據的影響最終將以審計機構的審計結果為準。此次出售資產不會影響公司經營活動的正常運作,不會影響公司的獨立性。此次交易價格經雙方協商一致確定,不存在損害公司及股東特別是中小股東利益的情形。
此次股權轉讓完成後,公司持有安譜實驗1198.95萬股(約30.19%)股權,安譜實驗將不再納入公司合併報表範圍,未來對公司財務報表將產生一定的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.